B-Complex Vitamins (B1, B2, B3/Niacin, B5, B6, B7/Biotin, B9/Folate, B12) for Neuropathy

Verdict: Depends on cause; megadose B6 harms nerves

B vitamins reliably help neuropathy only when it is caused by a confirmed B12 deficiency; for general or diabetic nerve pain the evidence is weak and inconsistent, and chronic high-dose B6 can actually cause the very nerve damage these supplements claim to treat.

C 🟠 C Weak Evidence Published with Warning

🔬Why this grade7-layer evidence engine

The grade is held to weak (Tier C) because the benefit splits sharply by cause. In documented B12 (cobalamin) deficiency, replacement is established standard care and patients improve (PMID 12975298). But for general peripheral neuropathy the Cochrane review found insufficient evidence of efficacy (PMID 18646107), and supportive trials are thin: a systematic review of methylcobalamin in diabetic neuropathy rested on small, low-quality studies (PMID 16008162), while the one positive benfotiamine RCT ran just six weeks, was industry-funded, and moved a single symptom score (PMID 18473286).

Crucially, the same supplements carry a real harm signal. High-dose vitamin B6 (pyridoxine) is the one B vitamin proven to cause sensory neuropathy at supplemental doses: a landmark case series documented severe nerve damage from megadosing (PMID 6308447), and a safety review confirmed dose-dependent toxicity, setting an upper limit near 100 mg/day (PMID 2192616). The cheap inactive form may even suppress active B6 function (PMID 28716455).

Regulators and clinics echo this caution. The UK NHS warns that 200 mg or more of B6 daily can cause peripheral neuropathy and caps supplements at 10 mg/day; Cleveland Clinic and Mayo Clinic note B6 is toxic to nerves at high levels; and the American Academy of Neurology rates the B-vitamin product Metanx as possibly no better than placebo for diabetic nerve pain. Test for deficiency first rather than self-dosing high-potency B-complex.

Bottom line: useful and uncontroversial only as targeted replacement for a confirmed deficiency, weak and unproven as a general nerve remedy, and potentially harmful if high-B6 products are taken long-term.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.41
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published with Warning
Confidence
87%
Highly consistent evidence
Evidence level
E1
Cochrane high-quality SR/MA

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.32
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.405
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (7)L2 · primary research & systematic reviews

Sun Y, Lai MS, Lu CJ. Effectiveness of vitamin B12 on diabetic neuropathy: systematic review of clinical controlled trials
PMID: 16008162 2005 系統性回顧 n = 741
Finding: Methylcobalamin showed consistent improvement in subjective neuropathic symptoms across pooled small trials; nerve conduction velocity changes inconsistent; trial quality generally low and heterogeneous (per-study direction positive but evidence base weak).
Academic
View on PubMed
Stracke H et al. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a 6-week, randomized, double-blind, placebo-controlled clinical study
PMID: 18473286 2008 RCT (double-blind) n = 165
Finding: Significant improvement in NSS with benfotiamine 600 mg vs placebo (p=0.033); modest effect size, short duration (6 weeks), single-symptom-score endpoint (per-study positive but limited).
⚠️ Industry-funded Effect size: [object Object]
View on PubMed
Vitamin B for treating peripheral neuropathy
PMID: 18646107 2008 Cochrane SR n = 741
Finding: Insufficient evidence to determine whether B vitamins are efficacious for peripheral neuropathy; small trials, short duration, heterogeneous interventions; possible short-term benefit signal in diabetic neuropathy on subjective symptoms but no robust effect on nerve conduction or function. (Notably does NOT cover B12-deficiency neuropathy, where replacement is established standard of care.)
🟢 High quality Academic
View on PubMed
Challenges in the identification of cobalamin-deficiency polyneuropathy
PMID: 12975298 2003 Observational n = 32
Finding: Patients with confirmed cobalamin deficiency and polyneuropathy showed symptomatic improvement with B12 replacement; supports targeted use in documented deficiency, NOT as generic neuropathy therapy.
Academic
View on PubMed
Schaumburg H, Kaplan J, Windebank A et al. Sensory neuropathy from pyridoxine abuse — a new megavitamin syndrome
PMID: 6308447 1983 個案報告 n = 7
Finding: Seven previously healthy adults developed severe progressive sensory neuropathy after chronic high-dose B6; partial recovery on cessation but residual deficits. SEMINAL evidence that B6 megadose is NEUROTOXIC — the same outcome the supplement is marketed to prevent.
Government
View on PubMed
Vitamin B6 safety issues
PMID: 2192616 1990 系統性回顧
Finding: Sensory neuropathy clearly documented at chronic intakes >=500-1000 mg/day; case reports as low as 100-200 mg/day with prolonged use; supports a tolerable upper intake (UL) of 100 mg/day in adults. Confirms dose-dependent neurotoxicity.
⚠️ Industry-funded
View on PubMed
Vrolijk MF, Opperhuizen A, Jansen EHJM et al. The vitamin B6 paradox: supplementation with high concentrations of pyridoxine leads to decreased vitamin B6 function
PMID: 28716455 2017 In vitro
Finding: High-dose pyridoxine HCl paradoxically inhibits PLP-dependent enzymes, plausibly explaining why supplementing with the inactive form (rather than P5P/PLP) can drive functional B6 deficiency and contribute to neuropathy. Mechanistic, not clinical.
🟠 Limited quality Academic
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
As part of a well-balanced diet, rich in fresh fruits and vegetables, daily intake of at least 400 mcg folic acid, 3 mg vitamin B6 and 5 mcg vitamin B12 may reduce the risk of vascular disease. source↗
L4b EU EFSA
Supportive
a cause and effect relationship has been established between the dietary intake of niacin and contribution to normal energy-yielding metabolism source↗
L4c UK NHS
Cautious
Taking 200mg or more a day of vitamin B6 can lead to a loss of feeling in the arms and legs known as peripheral neuropathy. ... Do not take more than 10mg of vitamin B6 a day in supplements unless advised to by a doctor. source↗
L4d TW TFDA / 衛福部
Supportive
目前公告之保健功效項目為:胃腸功能改善、調節血脂、護肝、骨質保健、免疫調節、輔助調整過敏體質、不易形成體脂肪、調節血糖、輔助調節血壓、抗疲勞、延緩衰老、輔助調節血鐵、牙齒保健、膝關節保健 source↗
L4e WHO
Cautious
Vitamins B and E, PUFA and multi-complex supplementation should not be recommended to reduce the risk of cognitive decline and/or dementia. source↗
L5a NIH Office of Dietary Supplements
Cautious
B vitamins lower blood homocysteine concentrations, but several large clinical trials found that this reduction did not lower the risk of cardiovascular events. source↗
L5b Mayo Clinic
Cautious
Vitamin imbalances. B vitamins — including B-1, B-6 and B-12 — are critical to nerve health. A deficiency in any of them can cause peripheral neuropathy. source↗
L5c Cleveland Clinic
Cautious
Other vitamins, especially B6, are toxic and cause peripheral neuropathy at high levels. source↗
L5d Harvard Health
Cautious
Nerve damage with numbness, tingling in the hands and legs source↗
L5e Specialty Society (condition-mapped)
Against
Metanx, consisting of l-methylfolate calcium, algae-S powder, pyridoxal-5'-phosphate, and methylcobalamin, is possibly no more likely than placebo to improve pain (SMD -0.43; 95% CI, -0.86 to 0.001; low confidence; 1 Class II study). source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬7 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-neuropathy-INT-b-vitamins-001 繁體中文版 →